Karen I. Sweiss
Clinical Assistant Professor, Pharmacy Practice
Email:
Related Sites:
About
Teaching and Supervision
Colloquium Lecture Series (PSCI 425), 8/25/2025 – 12/5/2025
Colloquium Lecture Series (PSCI 425), 8/25/2025 – 12/5/2025
Pathobiology of Cancer (PATH 511), 1/13/2025 – 5/2/2025
PDAT 9: Hematology/Oncology (PHAR 509), 1/13/2025 – 5/2/2025
PDAT 9: Hematology/Oncology (PHAR 509), 1/13/2025 – 5/2/2025
PDAT 9: Hematology/Oncology (PHAR 509), 1/13/2025 – 5/2/2025
PDAT 9: Hematology/Oncology (PHAR 509), 1/13/2025 – 5/2/2025
PDAT 9: Hematology/Oncology (PHAR 509), 1/13/2025 – 5/2/2025
Colloquium Lecture Series (PSCI 425), 8/26/2024 – 12/6/2024
Selected Grants
Title: Association of fludarabine exposure on car-t outcomes as a CIBMTR study, Center for International Blood and Marrow Transplant Research., 7/1/2025 - Present, No Obligated Amount Set; No Anticipated Amount Set
MC-FludT19-PK: An Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics in Patients With AML or MDS Underg, Medac GmbH., 2/9/2024 - 2/8/2029, Obligated Amount: $83791; Anticipated Amount: $83791
Multiple Myeloma Cellular Therapy Consortium Data Sharing, US Myeloma Immunotherapy Consortium., 10/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Heme-18: Minimal Residual Disease-Guided Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Multiple Myeloma Patients, Sanofi., 6/1/2023 - 11/30/2023, Obligated Amount: $2660818.02; No Anticipated Amount Set
"MC-FludT19-PK: An Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics in Patients With AML or MDS Undergoing Allogeneic Hematopoietic Stem Cell Transplantation ", Medexus., 6/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Expand Trial, Allogene., 5/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Monumental-3, Janssen Biotech., 4/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
AB-205-301: A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 plus Standard of Care versus Placebo plus Standard of Care in, AB-205-301., 3/3/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
BMS CA057-001: A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing CC-92480, Bortezomib and Dexamethasone (480Vd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM), BMS CA057-001., 3/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Sweiss, Karen, Wagner, Charlotte, Anto, Eric, Greene, Tom, Sun, Ryan, Gonzalez, Rebecca, Puglianini, Omar Castaneda, Freeman, Ciara, Ionescu, Filip, Patel, Krina, Ferreri, Christopher, Gaballa, Mahmoud, Shune, Leyla, McGuirk, Joseph, Sidana, Surbhi, Hovanky, Vanna, Khouri, Jack, Raza, Shahzad, Anwer, Faiz, Dima, Danai, Hashmi, Hamza, Davis, James, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry, Forsberg, Peter, Herr, Megan, Hansen, Doris K, Hakan Kocoglu, Mehmet, Sborov, Douglas. (2025). Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium. Transplantation and Cellular Therapy, 31, (12), 989-999. doi:10.1016/j.jtct.2025.08.015.
Zucchetti, Elisa, Sanchez, Matias, Wang, Meida, Ouyang, Hengde, Avila Rodriguez, Ana Maria, Sweiss, Karen, Galvez, Carlos, Mahmud, Nadim, Rondelli, Damiano. (2025). Effect of race and socio-economic status in allogeneic STEM cell transplantation. a single center experience.. Blood, 146, (Supplement 1), 7766-7766. doi:10.1182/blood-2025-7766.
Rodriguez, Ana Maria Avila, Zucchetti, Elisa, Sweiss, Karen, Sanchez, Matias, Galvez, Carlos, Mahmud, Nadim, Koshy, Matthew, Saraf, Santosh, Rondelli, Damiano. (2025). Haploidentical hematopoietic stem cell transplantation in adults with severe sickle cell disease: Long-term outcomes using a modified conditioning regimen with peripheral blood stem cells.. Blood, 146, (Supplement 1), 2487. doi:10.1182/blood-2025-2487.
An, Seungwon, Park, Youngmin, Mora, Celeste, Sweiss, Karen, Uzoka, Chukwuemeka, Sanchez, Matias, Zucchetti, Elisa, Campbell-Lee, Sally, Ma, Weiwei, Chen, Zhengjia, Rondelli, Damiano, Mahmud, Nadim. (2025). Beyond Body Weight: Investigating the Impact of Body Surface Area on Graft CD34+ Cell Dosing: A Single Center Experience. Cytotherapy, 101987. doi:10.1016/j.jcyt.2025.09.010.
Zhu, Shaoshi, Maahs, Lucas, Sweiss, Karen, Campbell‐Lee, Sally A, Mahmud, Nadim, Gordeuk, Victor R, Rondelli, Damiano, Saraf, Santosh L. (2025). Granulocyte colony‐stimulating factor may improve engraftment in adults with sickle cell disease undergoing non‐myeloablative haematopoietic stem cell transplantation. British Journal of Haematology, 207, (4), 1690-1693. doi:10.1111/bjh.70093.
Rivera, Amanda, Mahmud, Nadim, Sweiss, Karen, Gaitonde, Sujata, Avila-Rodriguez, Ana Maria, Sanchez, Matias, Uzoka, Emeka, Koshy, Matt, Galvez, Carlos, Zucchetti, Elisa, Lee, Sally Campbell, Borgetti, Scott, Weine, Stevan, Rondelli, Damiano. (2025). Global blood and marrow transplantation training for international physicians from LMICs: 5-year experience at UIC. Blood Global Hematology, 1, (2), 100009. doi:10.1016/j.bglo.2025.100009.
Maahs, Lucas, Avila, Ana Maria, Koshy, Matthew, Sweiss, Karen, Ahn, Kang-Hyun, Chen, Zhengjia, Uzoka, Chukwuemeka, Galvez, Carlos, Sanchez, Matias, Rubinstein, Paul, Quigley, John, Zucchetti, Elisa, Mahmud, Nadim, Aydogan, Bulent, Patel, Pritesh, Rondelli, Damiano. (2025). Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study.. Haematologica. doi:10.3324/haematol.2025.287457.
, . (2025). 2025 ASTCT Fundamentals of HCT Training Course and eBook Chapter. ASTCt.
Sweiss, Karen, Rodriguez, Ana Maria Avila, Quigley, John G, Sharp, Lisa, Kurzweil, Kaily, Sweis, Jaleel G, Calip, Gregory S, Hamilton, Zacharie, Uzoka, Chukwuemeka, Ilo, Elizabeth, Wolf, Elliot, Rondelli, Damiano, Sborov, Douglas W, Patel, Pritesh, Hofmeister, Craig C. (2025). Persistent opioid use is associated with a shorter myeloma survival. Supportive Care in Cancer, 33, (5), 374. doi:10.1007/s00520-025-09407-8.
Notable Honors
2025, CIBMTR Proposal Acceptance, CIBMTR
2024, Recipient of HealthTree Foundation Research Impact Award, HealthTree
2024, Selected as 1 of 9 abstracts for the 2025 Highlights of ASH, American Society of Hematology
2024, Real-World Data Award, HealthTree
2020, 2020 Best Oral Abstract Award, BMT Pharmacist Conference at the 2020 Transplantation and Cellular Therapy (TCT) Conference